OTLK NASDAQ
Outlook Therapeutics, Inc.
1W: -7.3%
1M: -5.3%
3M: -58.2%
YTD: -10.2%
1Y: -43.0%
3Y: -86.3%
5Y: -98.7%
$0.59
+0.02 (+3.13%)
Weekly Expected Move ±7.9%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-03-26
Earliest Filing
2025-01-16
Latest Filing
investor: 7
partner: 4
customer: 1
Counterparties (Filed by OTLK)
12 relationshipsCompanies named in OTLK's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| GMS Ventures and Investments | — | investor | Existing investor affiliated with directors exercising warrants for inducement | 2025-01-16 | View |
| Syntone Ventures, LLC | — | investor | Existing investor affiliated with a director exercising warrants for inducement | 2025-01-16 | View |
| BTIG | — | partner | Co-placement agent for the private placement | 2024-01-24 | View |
| GMS Ventures and Investments | — | investor | Existing investor committing to purchase shares and warrants | 2024-01-24 | View |
| Syntone Ventures, LLC | — | investor | Existing investor committing to purchase shares and warrants | 2024-01-24 | View |
| BTIG, LLC | — | partner | Sales agent and/or principal for at-the-market sales agreement | 2023-05-16 | View |
| H.C. Wainwright & Co. | — | partner | Counterparty to terminated at-the-market offering agreement | 2023-05-16 | View |
| GMS Ventures and Investments | — | investor | Investor entering into an Amended and Restated Investor Rights Agreement with Outlook Therapeutics, Inc. | 2022-04-22 | View |
| BioLexis Pte Limited | — | investor | Existing investor whose rights were terminated and whose shares were transferred to GMS Ventures and Investments. | 2022-04-22 | View |
| GMS Ventures & Investments | — | customer | Affiliate of BioLexis Pte. Ltd. that purchased shares in the offering | 2021-11-29 | View |
| BioLexis Pte. Ltd. | — | investor | Largest stockholder and affiliate of GMS Ventures & Investments | 2021-11-29 | View |
| H.C. Wainwright & Co. | — | partner | Sales agent for the At the Market Offering Agreement | 2021-03-26 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Delisting Notice | View | |
| 2026-09-18 | Other Events | View | |
| 2026-08-27 | Officer/Director Change; Exhibits | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-14 | Other Events; Exhibits | View | |
| 2026-08-12 | Earnings Release; Other Events; Exhibits | View | |
| 2026-07-24 | Officer/Director Change | View | |
| 2026-07-24 | Other Events; Exhibits | View | |
| 2026-07-16 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-06-26 | Delisting Notice | View | |
| 2026-06-16 | Other Events; Exhibits | View | |
| 2026-06-01 | Other Events; Exhibits | View | |
| 2026-05-29 | Other Events; Exhibits | View | |
| 2026-05-28 | Other Events; Exhibits | View | |
| 2026-05-26 | Other Events; Exhibits | View | |
| 2026-05-18 | Earnings Release; Exhibits | View | |
| 2026-05-13 | Material Agreement; Termination of Agreement; Earnings Release; Exhibits | Agreement | View |
| 2026-04-23 | Unregistered Equity Sales; Other Events; Exhibits | View | |
| 2026-04-21 | Other Events; Exhibits | View | |
| 2026-04-07 | Other Events; Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR